Abstract:The vast diversity of microbial communities reside in various locations of the human body, and they are collectively named as the ‘Human Microbiota.’ The majority of those microbes are found in the gastrointestinal and respiratory tracts. The microorganisms present in the gastrointestinal and the respiratory tracts are called the gut microbiota and the airway microbiota, respectively. These microbial communities are known to affect both the metabolic functions and the immune responses of the host. Among multiple factors determining the composition of gut microbiota, diet has played a pivotal role. The gut microbes possess enzymatic machinery for assimilating dietary fibers and releasing different metabolites, primarily short-chain fatty acids (SCFAs). The SCFAs modulate the immune responses of not only the gut but other distal mucosal sites as well, such as the lungs. Dysbiosis in normal gut flora is one of the factors involved in the development of asthma and other respiratory disorders. Of note, several human and murine studies have indicated significant cross-talk between gut microbiota and lung immunity, known as the gut–lung axis. Here, in this review, we summarize the recent state of the field concerning the effect of dietary metabolites, particularly SCFAs, on the “gut–lung axis” as well as discuss its impact on lung health. Moreover, we have highlighted the role of the “gut–lung axis” in SARS-CoV-2 mediated inflammation. Also, to analyze the global research progress on the gut–lung axis and to identify the knowledge gap in this field, we have also utilized the bibliographic tools Dimension database and VOS viewer analysis software. Through network mapping and visualization analysis, we can predict the present research trend and the possibility to explore new directions.

A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases

The role of gut-lung axis in COPD: Pathogenesis, immune response, and prospective treatment

Gut microbiota: A new insight into lung diseases

COPD and Gut–Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics

Gut‐lung axis and asthma: A historical review on mechanism and future perspective

Respiratory diseases and gut microbiota: relevance, pathogenesis, and treatment

Possible role of gut microbes and host’s immune response in gut–lung homeostasis

Gut-Lung Microbiota in Chronic Pulmonary Diseases: Evolution, Pathogenesis, and Therapeutics

The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease

Research Progress on the Association Between Gut Microbiota and Respiratory System Diseases

The role of oral microbiome in respiratory health and diseases

The Intriguing Connection Between the Gut and Lung Microbiomes

The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections

The gut–airway microbiome axis in health and respiratory diseases

Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches

The gut microbiota modulates airway inflammation in allergic asthma through the gut-lung axis related immune modulation: A review

The Gut Microbiota and Respiratory Diseases: New Evidence

Lung microbiota: implications and interactions in chronic pulmonary diseases

Cross-domain microbiomes: the interaction of gut, lung and environmental microbiota in asthma pathogenesis

Lung microbiome: new insights into the pathogenesis of respiratory diseases

Role of Microbiota on Lung Homeostasis and Diseases